Scholarlink

Objectives <p>This study aimed to compare blood choline levels and its correlations with bone mineral density (BMD) calcium, vitamin D, and parathyroid hormone (PTH) in patients with osteoporosis and healthy controls.</p> Background <p>Osteoporosis is a condition marked by reduced bone density and a higher risk of fractures, posing a major health concern. Cholinergic activity promotes bone formation, while its inhibition may contribute to bone loss.</p> Methods <p>Blood choline levels in 64 female participants, 38 with osteoporosis and 26 healthy controls. were measured using ELISA, and BMD was assessed via Dual-Energy X-Ray Absorptiometry (DEXA). Additional biochemical markers, including calcium, vitamin D, and PTH, were analyzed.</p> Results <p>Blood choline levels were significantly lower in the osteoporosis group compared to controls. Moderate correlations were observed between choline levels and BMD, as well as weak correlations with calcium, vitamin D, and PTH in patients with osteoporosis.</p> Conclusion <p>Lower choline levels in osteoporosis patients suggest a potential link between cholinergic deficiency and the disease, emphasizing the need for further research into cholinergic therapies for osteoporosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Investigation of Changes in Blood Choline Levels in Individuals Diagnosed with Osteoporosis: A Case–Control Study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月17日

查看全文
  • Volga Ozturk,
  • Elif Baris

摘要

Objectives

This study aimed to compare blood choline levels and its correlations with bone mineral density (BMD) calcium, vitamin D, and parathyroid hormone (PTH) in patients with osteoporosis and healthy controls.

Background

Osteoporosis is a condition marked by reduced bone density and a higher risk of fractures, posing a major health concern. Cholinergic activity promotes bone formation, while its inhibition may contribute to bone loss.

Methods

Blood choline levels in 64 female participants, 38 with osteoporosis and 26 healthy controls. were measured using ELISA, and BMD was assessed via Dual-Energy X-Ray Absorptiometry (DEXA). Additional biochemical markers, including calcium, vitamin D, and PTH, were analyzed.

Results

Blood choline levels were significantly lower in the osteoporosis group compared to controls. Moderate correlations were observed between choline levels and BMD, as well as weak correlations with calcium, vitamin D, and PTH in patients with osteoporosis.

Conclusion

Lower choline levels in osteoporosis patients suggest a potential link between cholinergic deficiency and the disease, emphasizing the need for further research into cholinergic therapies for osteoporosis.